This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Phillips, M. A. Articles by Szabadi, E. Search for Related Content PubMed PubMed Citation Articles by Phillips, M. A. Articles by Szabadi, E. Social Bookmarking                         What's this?

The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man

Division of Psychiatry, University of Nottingham, UK

R. W. Langley

Division of Psychiatry, University of Nottingham, UK

C. M. Bradshaw

Division of Psychiatry, University of Nottingham, UK

E. Szabadi

Division of Psychiatry, University of Nottingham, UK

Both the acoustic startle (eyeblink) response and the N1/P2 complex of the auditory evoked potential can be suppressed by presentation of a brief low-intensity stimulus 30-500 ms before the ‘startle-eliciting’ stimulus (‘prepulse inhibition’, PPI). We examined the effects of three antidepressants on PPI of these two responses. Fifteen males (19-30 years) participated in four weekly sessions, in which they received placebo, amitriptyline (100 mg), fluvoxamine (100 mg), and reboxetine (4 mg) (p.o.), according to a balanced double-blind design. Twenty minute simultaneous recordings of electromyographic (EMG) responses of the orbicularis oculi muscle of the right eye and vertex auditory evoked potentials were carried out 195 min after drug ingestion. Sound stimuli (1 kHz) were presented in 40 trials separated by variable intervals (mean 25 s): (1) 40 ms, 115 dB (‘pulse alone’, 20 trials) and (2) 40 ms, 85 dB, followed after 120 ms by 40 ms, 115 dB (‘prepulse/pulse’, 20 trials). Under the placebo condition, both the EMG response and the N1/P2 complex showed >50% PPI. Fluvoxamine and reboxetine did not significantly alter the amplitude or PPI of either response. Amitriptyline significantly reduced the amplitudes of both responses; it had no effect on PPI of the EMG response, but significantly attenuated PPI of the N1/P2 complex. Amitriptyline also reduced arousal, as indicated by an increase in power of low-frequency electroencephalographic waves. The results confirm the susceptibility of the N1/P2 complex to PPI. The reduction of the amplitudes of the EMG response and N1/P2 complex by amitriptyline may be related to its sedative action. The differential effect of amitriptyline on PPI of the N1/P2 complex supports the suggestion that different mechanisms may be involved in PPI of this response and PPI of the N1/P2 complex.

Journal of Psychopharmacology, Vol. 14, No. 1, 40-45 (2000)
DOI: 10.1177/026988110001400105


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. Al-Abduljawad, F. Baqui, R. Langley, C. Bradshaw, and E. Szabadi Effects of threat of electric shock and diazepam on the N1/P2 auditory-evoked potential elicited by low-intensity auditory stimuli J Psychopharmacol, November 1, 2008; 22(8): 828 - 835. [Abstract] [PDF]

				S. J. Graham, J. C. Scaife, R. W. Langley, C. M. Bradshaw, E. Szabadi, L. Xi, T. Crumley, N. Calder, K. Gottesdiener, and J. A. Wagner Effects of lorazepam on fear-potentiated startle responses in man J Psychopharmacol, May 1, 2005; 19(3): 249 - 258. [Abstract] [PDF]

				S. J. Graham, J. C. Scaife, A. M. B. Verduzco, R. W. Langley, C. M. Bradshaw, and E. Szabadi Effects of Quetiapine and Haloperidol on Prepulse Inhibition of the Acoustic Startle (Eyeblink) Response and the N1/P2 Auditory Evoked Response in Man J Psychopharmacol, June 1, 2004; 18(2): 173 - 180. [Abstract] [PDF]

				S. J. Graham, R. W. Langley, A. M. B. Verduzco, C. M. Bradshaw, and E. Szabadi Effects of ketanserin and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man J Psychopharmacol, January 1, 2002; 16(1): 15 - 22. [Abstract] [PDF]

				K. A. J. Abduljawad, R. W. Langley, C. M. Bradshaw, and E. Szabadi Effects of clonidine and diazepam on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man J Psychopharmacol, July 1, 2001; 15(4): 237 - 242. [Abstract] [PDF]

				S. J. Graham, R. W. Langley, C. M. Bradshaw, and E. Szabadi Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man J Psychopharmacol, July 1, 2001; 15(4): 243 - 250. [Abstract] [PDF]

				M. A. Phillips, E. K. Oxtoby, R. W. Langley, C. M. Bradshaw, and E. Szabadi Effects of acute tryptophan depletion on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man J Psychopharmacol, May 1, 2000; 14(3): 258 - 265. [Abstract] [PDF]